EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia

Alexander McDermott, Reece M Gardner, Monika Papayova, Agnieszka B Wisniewska, Cyrielle Doigneaux, Soran Mohammed, Ali Tavassoli iD

Journal of the American Chemical Society · 23.09.2026 · 148 (37) · 39580-39590

DOI: 10.1021/jacs.6c08218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 14.09.2026. Verfasst von Alexander McDermott und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, University of Southampton, SouthamptonSO17 1BJ, U.K. Hauptthemen laut MEDLINE: Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Peptides, Cyclic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council (EPSRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a systematic approach to convert cyclic peptide protein–protein interaction (PPI) inhibitors into functional degraders. We compare traditional PEG-based linkers with custom bifunctional amino acids that embed a Von Hippel-Lindau (VHL)-recruiting ligand and variable-length linkers for direct incorporation into cyclic peptides during solid-phase peptide synthesis (SPPS). Using an optimized split-intein circular ligation of peptides and proteins (SICLOPPS)-derived hypoxia-inducible factor 1 (HIF-1) inhibitor as the warhead, we generate cyclic peptide PROTACs (CP-PROTACs) that form a ternary complex with VHL and degrade HIF-1α across multiple cancer cell lines, suppressing hypoxia-response signaling. Degradation is oxygen-state dependent, being robust at 3% oxygen but lost at 1% oxygen. We show that the degrader remains engagement- and degradation-competent at 1% oxygen but is outpaced by HIF-1α resynthesis, revealing a kinetic ceiling on proteolytic-targeting chimeras (PROTAC) efficacy against rapidly replenished proteins. The modular amino acid building blocks reported provide a generalizable blueprint for converting cyclic peptides into degraders, extending targeted protein degradation to previously intractable proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Von Hippel-Lindau Tumor Suppressor ProteinHypoxia-Inducible Factor 1, alpha SubunitPeptides, CyclicHumansProteolysis Targeting ChimeraProteolysisCell HypoxiaCell Line, Tumor

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinHypoxia-Inducible Factor 1, alpha SubunitPeptides, CyclicProteolysis Targeting ChimeraVHL protein, humanHIF1A protein, human

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, University of Southampton, SouthamptonSO17 1BJ, U.K.

ORCID-Profile: Ali Tavassoli

Förderung

  • Engineering and Physical Sciences Research Council (EPSRC)

Zitieren

APA

McDermott, A., Gardner, R. M., Papayova, M., Wisniewska, A. B., Doigneaux, C., Mohammed, S., & Tavassoli, A. (2026). Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia. Journal of the American Chemical Society, 148(37), 39580-39590. https://doi.org/10.1021/jacs.6c08218

Vancouver

McDermott A, Gardner RM, Papayova M, Wisniewska AB, Doigneaux C, Mohammed S, et al. Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia. Journal of the American Chemical Society. 2026;148(37):39580-39590. doi:10.1021/jacs.6c08218

BibTeX
@article{McDermott2026,
  author = {McDermott, Alexander and Gardner, Reece M and Papayova, Monika and Wisniewska, Agnieszka B and Doigneaux, Cyrielle and Mohammed, Soran and Tavassoli, Ali},
  title = {Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {37},
  pages = {39580--39590},
  doi = {10.1021/jacs.6c08218}
}
Kostenlos starten →